The Effect of CORT118335 on Olanzapine-Induced Weight Gain
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Olanzapine
Related studies linked through entity extraction aliases.
Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder
- Status
- UNKNOWN
- Phase
- PHASE4
Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia
- Status
- RECRUITING
- Phase
- PHASE1
Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care
- Status
- UNKNOWN
- Phase
- PHASE2
Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis
- Status
- UNKNOWN
- Phase
- PHASE2
Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
- Status
- TERMINATED
- Phase
- PHASE3
"Olanzapine for Prevention of Chemotherapy Induced Nausea and Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy (HEC)"
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2